What Is a Triatoma Bite
A triatoma bite comes from insects in the genus Triatoma, commonly called kissing bugs. These blood-feeding insects are found across the Americas, especially in rural and suburban areas of Latin America and increasingly in the southern United States. The bite itself is usually painless, but the bug often defecates near the wound, leaving behind the parasite Trypanosoma cruzi, which causes Chagas disease. According to the CDC, triatomine bugs have been documented in 28 U.S. states, with the highest concentrations in Texas, Arizona, and New Mexico. The CDC provides updated maps and identification guides on its vector-borne disease page here.
Triatoma species are nocturnal and typically feed on the faces of sleeping mammals, including humans and dogs. They are attracted to carbon dioxide and body heat, and they often crawl into cracks in walls, thatched roofs, or mud-brick homes. In endemic regions, housing improvements such as plastered walls and screened windows have reduced infestation rates. The World Health Organization tracks Chagas disease as a neglected tropical disease, estimating millions of people are infected globally, with most cases concentrated in Latin America. WHO data on Chagas disease is available on its official page here.
Symptoms and Health Risks of a Triatoma Bite
Acute Phase Signs
In the acute phase, which lasts weeks to months, many people show no symptoms or only mild ones. When present, signs include swelling at the bite site (a Romaña sign if near the eye), fever, fatigue, body aches, and swollen lymph nodes. The acute phase can be more severe in young children and immunocompromised individuals. The American Heart Association notes that acute Chagas can cause myocarditis or meningoencephalitis in rare cases, and it publishes clinical guidance on its website here.
Chronic Complications
About 20 to 30 percent of infected people develop chronic Chagas disease decades later, often with no early warning. The most serious outcomes are cardiomyopathy and megacolon or megaesophagus, which can require surgery. The chronic phase is driven by persistent low-level parasite presence and immune-mediated tissue damage. The CDC estimates that more than 300,000 people in the U.S. may have Chagas disease, mostly acquired in endemic countries but some through local vector exposure. Research on U.S. cardiac cases linked to Chagas is published in journals indexed by the National Institutes of Health here.
Diagnosis, Treatment, and Prevention
Testing and Medical Care
Diagnosis involves blood tests that detect T. cruzi antibodies or parasite DNA. Serologic screening is recommended for people with a history of triatoma bites, residence in endemic areas, or unexplained cardiomyopathy. The FDA has approved two screening tests for blood donors in the United States to prevent transfusion-related transmission. Early treatment with antiparasitic drugs benznidazole and nifurtimox is most effective during the acute phase and is available through the CDC Drug Service for qualifying patients.
Prevention and Vector Control
Prevention focuses on reducing bug exposure and improving housing. Insecticide spraying with residual pyrethroids, sealing cracks, using bed nets, and removing animal burrows near homes lower infestation risk. The WHO and national programs in Latin America have implemented vector-s